NYSE | TSX: ACB
EDMONTON, AB, Sept. 8,
2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company " or
"Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company
defining the future of cannabinoids worldwide, today announced that
Miguel Martin has been appointed
Chief Executive Officer, effective immediately. With deep,
diverse experience in consumer packaged goods, highly regulated
industries and the U.S. cannabinoid industry, Miguel is
well-positioned to execute the next phase of Aurora's business
transformation, with a focus on commercial strategy. Michael Singer, who has served as Interim CEO
since February 2020, has stepped down
from his temporary role and will remain Executive Chairman.
Michael Singer stated, "In his
short time at Aurora, Miguel has demonstrated decisive leadership.
Miguel is a highly experienced executive with an exceptional track
record of performance in a number of consumer products categories.
After an extensive search which included evaluation of many
highly-respected candidates, Miguel stood apart with both strong
commercial and cannabinoid sector expertise, as well as his passion
for Aurora's success. The Aurora Board and I firmly believe that
under Miguel's leadership, Aurora's strategic direction going
forward will be characterized by leading market performance,
sustainable growth, profitability and value creation for
shareholders."
"I am excited to step into the role of CEO at this inflection
point in Aurora's business," said Miguel
Martin. "In my early days, I have seen the tremendous
potential of this organization firsthand- a combination of deep
industry knowledge, commitment to quality, great brands and a
passion for patients and consumers that is truly differentiated. I
am confident that we have the infrastructure and capabilities for
long term success in the global cannabinoid industry. Given my 25
years of executing against regulated product opportunities,
including serving as President of one of the largest electronic
cigarette companies, I believe we will be successful both with the
current portfolio and emerging margin accretive formats."
About Miguel Martin
Mr. Martin is a 25-year consumer packaged goods industry veteran
who joined Aurora from Reliva where he served as Chief Executive
Officer. He assumed the role of Chief Commercial Officer of Aurora
in July 2020. Prior to Reliva, Mr.
Martin was the President of Logic Technology, one of the largest
manufacturers of electronic cigarettes. He also held the position
of Senior Vice President and General Manager of Altria Sales &
Distribution. Mr. Martin has deep experience operating in highly
regulated industries which will be very additive to Aurora's
portfolio of high quality, rigorously tested and compliant
cannabinoid product formats.
About Aurora
Aurora is a global leader in the cannabis industry serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler,
and Reliva CBD. Providing customers with innovative,
high-quality cannabis products, Aurora's brands continue to break
through as industry leaders in the medical, performance, wellness
and recreational markets wherever they are launched. For more
information, please visit our website at www.auroramj.com.
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and is a constituent of the S&P/TSX Composite
Index.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words
such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. These forward-looking
statements are only predictions. Various assumptions were used in
drawing the conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions, estimates and
assumptions of management in light of management's experience and
perception of historical trends, current conditions and expected
developments at the date the statements are made, such as current
and future market conditions, the current and future regulatory
environment and future approvals and permits. Forward-looking
statements are subject to a variety of risks, uncertainties and
other factors that management believes to be relevant and
reasonable in the circumstances could cause actual events, results,
level of activity, performance, prospects, opportunities or
achievements to differ materially from those projected in the
forward-looking statements, including the risks associated with:
entering the U.S. market, the ability to realize the anticipated
benefits associated with the acquisition of Reliva, achievement of
Aurora's business transformation plan, general business and
economic conditions, changes in laws and regulations, product
demand, changes in prices of required commodities, competition, the
effects of and responses to the COVID-19 pandemic and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 10, 2019 (the "AIF") and filed
with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com and filed with and
available on the SEC's website at www.edgar.gov. The Company
cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also
adversely affect its results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-appoints-miguel-martin-as-ceo-301125312.html
SOURCE Aurora Cannabis Inc.